Literature DB >> 12553514

Tumors of the head of the fibula: good function after resection without ligament reconstruction in 6 patients.

Paul A Einoder1, Peter F M Choong.   

Abstract

Tumors of the proximal fibula are rare. Wide resection includes adjacent knee-stabilizing structures. Unlike treatment of traumatic disruption of the lateral ligamentous structures of the knee, wide resection of the fibular head for a tumor may not require reconstruction. After 14 years of follow-up, function was satisfactory in 6 consecutive cases where resection of the fibular head was done without ligamentous reconstruction.

Entities:  

Mesh:

Year:  2002        PMID: 12553514     DOI: 10.1080/000164702321039633

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  5 in total

1.  Reconstruction of lateral knee joint stability following resection of proximal fibula tumors.

Authors:  Shi-Chang Zhao; Chang-Qing Zhang; Chun-Lin Zhang
Journal:  Exp Ther Med       Date:  2013-11-26       Impact factor: 2.447

2.  Surgical management of proximal fibular tumors: A report of 12 cases.

Authors:  Hiroyuki Inatani; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Akihiko Takeuchi; Shinji Miwa; Takashi Higuchi; Kensaku Abe; Yuta Taniguchi; Satoshi Yamada; Hideki Okamoto; Takanobu Otsuka; Hiroyuki Tsuchiya
Journal:  J Bone Oncol       Date:  2016-06-08       Impact factor: 4.072

3.  Fibulectomy for Primary Proximal Fibular Bone Tumors: A Functional and Clinical Outcome in 46 Patients.

Authors:  Zile Singh Kundu; Milind Tanwar; Parveen Rana; Rajeev Sen
Journal:  Indian J Orthop       Date:  2018 Jan-Feb       Impact factor: 1.251

4.  Secondary Chondrosarcoma from an Osteochondroma of the Proximal Tibia Involving the Fibula.

Authors:  Hwan Seong Cho; Ilkyu Han; Han-Soo Kim
Journal:  Clin Orthop Surg       Date:  2017-05-08

5.  Is double-approach surgery and tenodesis without a gastrocnemius flap better for dealing with proximal fibular osteosarcoma?

Authors:  Jun Wan; Can Zhang; Hong-Bo He
Journal:  World J Surg Oncol       Date:  2018-03-27       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.